Neoadjuvant Therapy for Breast Cancer

Detection and Characterization of Circulating Tumor Cells

Breast Cancer Bone Metastasis - From Molecular Insights to Novel Therapeutics

Breast Cancer and Metastasis: On the Way toward Individualized Therapy

Surgical Issues for Management of Local-regional Breast Cancer Recurrence

Re-irradiation after Ipsilateral Breast Recurrence after BCS

Do We Need Systemic Treatment in Patients with Locoregional Recurrence?

Oncogenic PIK3CA Mutations: Targeted Therapies and Diagnostics

How Can We Overcome PI3K Activation? - Emerging PI3K Inhibitors

Targeting MTOR Pathway: Clinical Implication in Therapy

Changing Treatment Paradigm of HER2 Positive Breast Cancer: Clinical Application of New Agents

Brain Metastases in HER2-positive Breast Cancer Patients

Determinant of Resistance to Trastuzumab in Adjuvant Setting

Tailored Adjuvant Therapy Based on Genomic Assays

Changing the Medical Pathway Based on BRCA Mutation Status

Interpreting Genetic Test Results for BRCA1 and BRCA2

NO FURTHER AXILLARY DISSECTION IN SENTINEL LYMPH NODE-NEGATIVE BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH INITIAL CYTOLOGICALLY-PROVEN AXILLARY NODE METASTASIS

ROLE OF AXILLARY CLEARANCE WITH TUMOR POSITIVE SENTINEL NODE IN MASTECTOMY GROUP: IS THE RESULTS OF ACOSOG Z0011 TRIAL ADAPTABLE TO MASTECTOMY PATIENT?

REAL-TIME 3D VIRTUAL NAVIGATION - IT AND BREAST SURGERY -

NEOADJUVANT CHEMOTHERAPY IN YOUNG AGE BREAST CANCER: SURVIVAL BENEFIT OVER ADJUVANT CHEMOTHERAPY IN CLINICALLY T2 NODE POSITIVE PATIENTS

BREAST CANCER 2013: TIME TO ACKNOWLEDGE MEDICAL THERAPY FIRST

EARLY FAILURE OF LOCALLY ADVANCED BREAST CANCERS TO NEOADJUVANT CHEMOTHERAPY: IDENTIFYING THE PATIENTS WHO DO NOT HAVE BENEFIT FROM NEOADJUVANT CHEMOTHERAPY

CAN POST OPERATIVE RADIOTHERAPY ADVERSELY AFFECT FLAP BASED IMMEDIATE SKIN SPARING MASTECTOMIES AND RECONSTRUCTIONS?

A SINGLE-INSTITUTION COMPARISON BETWEEN APBI (ACCELERATED PARTIAL BREAST IRRADIATION) USING MULTICATHETER BRACHYTHERAPY AND WBI (WHOLE BREAST RADIATION) IN BREAST CANCER WITH "CAUTIONARY" OR "UNSUITABLE" BY ASTRO GUIDELINE

ONCOLPASTIC BREAST-CONSERVING SURGERY WITH INTERCOSTAL ARTERY PERFORATOR FLAP

THE EFFECTS OF BREAST HEALTH EDUCATION PROGRAM BASED ON SELF-EFFICACY THEORY AND PERSONAL NARRATIVE ON SELF-EFFICACY, KNOWLEDGE, AND RESILIENCE IN WOMEN WITH BREAST CANCER

QUALITATIVE ANALYSIS OF WOMEN'S KNOWLEDGE, ATTITUDES AND EXPERIENCES REGARDING URINARY SYMPTOMS ASSOCIATED WITH AROMATASE INHIBITORS FOR EARLY STAGE BREAST CANCER

FACTORS INFLUENCING QUALITY OF LIFE IN BREAST CANCER PATIENTS WITH HORMONE THERAPY

FEAR OF RECURRENCE AFTER BREAST CANCER TREATMENT

ASSOCIATED FACTORS WITH CHANGES IN COGNITIVE FUNCTION IN BREAST CANCER PATIENTS RECEIVED CHEMOTHERAPY (BASED ON THE CONCEPTUAL MODEL OF CHEMOTHERAPY-RELATED CHANGES IN COGNITIVE FUNCTION)

DEVELOPMENT AND VALIDATION OF CHEMOTHERAPY-INDUCED ALOPECIA DISTRESS SCALE (CADS) FOR BREAST CANCER PATIENTS

EXPERIENCE OF IRANIAN MEN IN LIVING WITH A SPOUSE WITH BREAST CANCER?

A VALIDATION STUDY OF CANCER STIGMA SCALE FOR KOREAN PATIENTS (CSS-K)

PROGNOSTIC RELEVANCE OF BIOLOGICAL SUBTYPE OVERRIDING TNM STAGING IN BREAST CANCER: DISCORDANCE BETWEEN STAGE AND BIOLOGY

THE CLINICAL IMPACT OF 21-GENE RECURRENCE SCORE ON TREATMENT DECISION FOR PATIENTS WITH HORMONE RECEPTOR - POSITIVE EARLY BREAST CANCER IN KOREA

IDENTIFICATION OF THE PATIENTS WITH A POOR PROGNOSIS AMONG ESTROGEN RECEPTOR - POSITIVE BREAST CANCER WITH THE INTERMEDIATE ONCOTYPE DX RECURRENCE SCORE

STANDARDIZATION OF KI67 ASSESSMENT FOR EFFICIENT USE OF THE ONCOTYPE DX ASSAY IN BREAST CANCER PATIENTS

CLINICAL USEFULNESS OF AUTOMATED ASSESSMENT OF KI-67 PROLIFERATIVE ACTIVITY USING A PUBLIC DOMAIN IMAGE ANALYSIS SOFTWARE, IMMUNORATIO

A ROLE OF BREAST DENSITY AS A PROGNOSTIC FACTOR FOR LATE DISTANT METASTASIS IN PREMENOPAUSAL, HORMONE RESPONSIVE/HER2 NEGATIVE BREAST CANCER PATIENTS AFTER COMPLETION OF 5 YEARS OF ADJUVANT THERAPY

IMPACT OF INITIAL SURGICAL TREATMENT DELAY ON SURVIVAL ACCORDING TO HORMONE RESPONSIVENESS IN BREAST CANCER

MALIGNANT PHYLLODES TUMOR OF THE BREAST: CLINICAL OUTCOMES OF PATIENTS TREATED WITH SURGERY AND RADIOTHERAPY

TCGA, the Big Data for Breast Cancer – Introduction and Method for Data Mining

Genomic Approaches to Overcome Limitation in Tissue Access and Tumor Heterogeneity

Clinical Trials Based on Genomics Data Mining

Where Are We in Asia, Two Decades after the Discovery of BRCA1 and BRCA2

Systemic Review of BRCA Mutation and Variants of Unknown Significance in Asia

Risk Assessment and Modifiers of the Risks of Breast Cancer and BRCA Mutation in Asia

Status of Genetic Counseling and Genetic Testing in Asian Countries

Early Diagnosis and Risk Reduction Strategy in BRCA Carriers

Outcomes for Asian BRCA Carriers

Beyond BRCA Mutation in Hereditary Breast Cancer

Upfront Surgery vs. Surgery after Neoadjuvant Chemotherapy

Oncology Issue: Are We Ready to Use Different Strategy according to Intrinsic Subtypes?

Surgical Issue: Can SLN Biopsy Guide Extent of LN Dissection after Neoadjuvant Treatment?